Evidence map›Paper›PMID 30707508›Full record

ReviewAdvanced healthcare materials2019

Current and Future Perspectives on Skin Tissue Engineering: Key Features of Biomedical Research, Translational Assessment, and Clinical Application.

Justine R Yu, Javier Navarro, James C Coburn, Bhushan Mahadik, Joseph Molnar, James H Holmes, Arthur J Nam, John P Fisher

Open access · greenAbstract readReview
In one paragraph

Review in Advanced healthcare materials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 203 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Fucoidan in cancer therapy: from biomedical application to medicinal chemistry approach.Journal of materials science. Materials in medicine · 2025
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. The Bioengineering of Microspheric Skin Organoids and Their Application in Drug Screening.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Gels (Basel, Switzerland) · 2025
    Review
  19. Article
  20. Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Justine R YuFischell Department of Bioengineering, University of Maryland, College Park, College Park, MD, 20742, USA.
Javier NavarroFischell Department of Bioengineering, University of Maryland, College Park, College Park, MD, 20742, USA.
James C CoburnFischell Department of Bioengineering, University of Maryland, College Park, College Park, MD, 20742, USA.
Bhushan MahadikFischell Department of Bioengineering, University of Maryland, College Park, College Park, MD, 20742, USA.ORCID 0000-0001-5989-9880
Joseph MolnarWake Forest Baptist Medical Center, Winston-Salem, NC, 27157, USA.
James H HolmesWake Forest Baptist Medical Center, Winston-Salem, NC, 27157, USA.
Arthur J NamDivision of Plastic, Reconstructive and Maxillofacial Surgery, R. Adams Cowley Shock Trauma Center, University of Maryland, Baltimore, Baltimore, MD, 21201, USA.
John P FisherFischell Department of Bioengineering, University of Maryland, College Park, College Park, MD, 20742, USA.ORCID 0000-0002-4019-348X
University of Maryland, College Park · USAtrium Health Wake Forest Baptist · USUniversity of Maryland, Baltimore · USUnited States Food and Drug Administration · US

Funding

Training and Dissemination CoreP41EB023833 · NIBIB · UNIV OF MARYLAND, COLLEGE PARK · PI MIKOS, ANTONIOS G. · 2017 to 2021
$6.2M
NIBIB NIH HHS P41 EB023833
6 · The paper itself

Abstract

The skin is responsible for several important physiological functions and has enormous clinical significance in wound healing. Tissue engineered substitutes may be used in patients suffering from skin injuries to support regeneration of the epidermis, dermis, or both. Skin substitutes are also gaining traction in the cosmetics and pharmaceutical industries as alternatives to animal models for product testing. Recent biomedical advances, ranging from cellular-level therapies such as mesenchymal stem cell or growth factor delivery, to large-scale biofabrication techniques including 3D printing, have enabled the implementation of unique strategies and novel biomaterials to recapitulate the biological, architectural, and functional complexity of native skin. This progress report highlights some of the latest approaches to skin regeneration and biofabrication using tissue engineering techniques. Current challenges in fabricating multilayered skin are addressed, and perspectives on efforts and strategies to meet those limitations are provided. Commercially available skin substitute technologies are also examined, and strategies to recapitulate native physiology, the role of regulatory agencies in supporting translation, as well as current clinical needs, are reviewed. By considering each of these perspectives while moving from bench to bedside, tissue engineering may be leveraged to create improved skin substitutes for both in vitro testing and clinical applications.

Indexed as

AnimalsBiocompatible MaterialsHumansPrinting, Three-DimensionalRegenerationSkinSkin, ArtificialTissue EngineeringTissue ScaffoldsTranslational Research, BiomedicalWound HealingBiocompatible Materialsclinical perspectivesskin regenerationtissue engineeringwound healing

Identifiers

PMID30707508
PMCPMC10290827
OpenAlexW2914857359

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.